Innate Pharma, SA — Form D

Innate Pharma, SA of MARSEILLE, I0, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-31. The offering totals $27.4M, of which $27.4M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2014-01-31
• Form: D
• Accession: 0001598599-14-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $27.4M
• Amount sold: $27.4M
• Investors: 6
• Date of first sale: 2013-11-19
• Security types: equity
• Revenue range: $5,000,001 - $25,000,000
• SEC file number: 021-211065

Issuer

• Name: Innate Pharma, SA
• CIK: 0001598599
• Entity type: Limited Liability Company
• Jurisdiction: FRANCE
• Address: 117 AVENUE DE LUMINY, MARSEILLE, I0, 13009
• Phone: 01133430303030

Officers, directors & promoters (1)

More

• CIK 1598599 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search